Llobet D - Search Results

1

Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants.

Dolcet X, Llobet D, Encinas M, Pallares J, Cabero A, Schoenenberger JA, Comella JX, Matias-Guiu X. Dolcet X, et al. Among authors: llobet d. J Biol Chem. 2006 Aug 4;281(31):22118-22130. doi: 10.1074/jbc.M601350200. Epub 2006 May 30. J Biol Chem. 2006. PMID: 16735506 Free article.

2

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

Llobet D, Eritja N, Encinas M, Llecha N, Yeramian A, Pallares J, Sorolla A, Gonzalez-Tallada FJ, Matias-Guiu X, Dolcet X. Llobet D, et al. Oncogene. 2008 Apr 17;27(18):2513-24. doi: 10.1038/sj.onc.1210924. Epub 2007 Nov 5. Oncogene. 2008. PMID: 17982483

3

Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.

Sorolla A, Yeramian A, Dolcet X, Pérez de Santos AM, Llobet D, Schoenenberger JA, Casanova JM, Soria X, Egido R, Llombart A, Vilella R, Matias-Guiu X, Marti RM. Sorolla A, et al. Among authors: llobet d. Br J Dermatol. 2008 Mar;158(3):496-504. doi: 10.1111/j.1365-2133.2007.08390.x. Epub 2008 Jan 17. Br J Dermatol. 2008. PMID: 18205878

4

Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

Pallares J, Martínez-Guitarte JL, Dolcet X, Llobet D, Rue M, Palacios J, Prat J, Matias-Guiu X. Pallares J, et al. Among authors: llobet d. J Pathol. 2004 Dec;204(5):569-77. doi: 10.1002/path.1666. J Pathol. 2004. PMID: 15481028

5

NF-kB in development and progression of human cancer.

Dolcet X, Llobet D, Pallares J, Matias-Guiu X. Dolcet X, et al. Among authors: llobet d. Virchows Arch. 2005 May;446(5):475-82. doi: 10.1007/s00428-005-1264-9. Epub 2005 Apr 27. Virchows Arch. 2005. PMID: 15856292 Review.

6

FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis.

Dolcet X, Llobet D, Pallares J, Rue M, Comella JX, Matias-Guiu X. Dolcet X, et al. Among authors: llobet d. Lab Invest. 2005 Jul;85(7):885-94. doi: 10.1038/labinvest.3700286. Lab Invest. 2005. PMID: 15864316 Free article.

7

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.

Llobet D, Eritja N, Encinas M, Sorolla A, Yeramian A, Schoenenberger JA, Llombart-Cussac A, Marti RM, Matias-Guiu X, Dolcet X. Llobet D, et al. Anticancer Drugs. 2008 Feb;19(2):115-24. doi: 10.1097/CAD.0b013e3282f24031. Anticancer Drugs. 2008. PMID: 18176107

8

Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.

Gallel P, Pallares J, Dolcet X, Llobet D, Eritja N, Santacana M, Yeramian A, Palomar-Asenjo V, Lagarda H, Mauricio D, Encinas M, Matias-Guiu X. Gallel P, et al. Among authors: llobet d. Hum Pathol. 2008 Jul;39(7):994-1001. doi: 10.1016/j.humpath.2007.11.015. Epub 2008 May 27. Hum Pathol. 2008. PMID: 18508109

9

Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.

Llobet D, Pallares J, Yeramian A, Santacana M, Eritja N, Velasco A, Dolcet X, Matias-Guiu X. Llobet D, et al. J Clin Pathol. 2009 Sep;62(9):777-85. doi: 10.1136/jcp.2008.056101. Epub 2008 Oct 31. J Clin Pathol. 2009. PMID: 18977806 Review.

10

The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

Llobet D, Eritja N, Yeramian A, Pallares J, Sorolla A, Domingo M, Santacana M, Gonzalez-Tallada FJ, Matias-Guiu X, Dolcet X. Llobet D, et al. Eur J Cancer. 2010 Mar;46(4):836-50. doi: 10.1016/j.ejca.2009.12.025. Epub 2010 Jan 12. Eur J Cancer. 2010. PMID: 20071162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters